Ocular Therapeutix, Inc. (OCUL)
8.165
-0.16
(-1.98%)
USD |
NASDAQ |
Mar 26, 14:11
Ocular Therapeutix Cash from Investing (Quarterly) : -2.839M for Dec. 31, 2025
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Regeneron Pharmaceuticals, Inc. | 220.30M |
| EyePoint Plc | -74.67M |
| ACADIA Pharmaceuticals, Inc. | -55.87M |
| Vertex Pharmaceuticals, Inc. | -288.10M |
| Rhythm Pharmaceuticals, Inc. | 30.35M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -54.25M |
| Cash from Financing (Quarterly) | 449.38M |
| Free Cash Flow | -216.89M |
| Free Cash Flow Per Share (Quarterly) | -0.2561 |
| Free Cash Flow to Equity (Quarterly) | -57.05M |
| Free Cash Flow to Firm (Quarterly) | -54.26M |
| Free Cash Flow Yield | -14.19% |